scispace - formally typeset
J

J. R. Stothard

Researcher at American Museum of Natural History

Publications -  14
Citations -  787

J. R. Stothard is an academic researcher from American Museum of Natural History. The author has contributed to research in topics: Schistosomiasis & Population. The author has an hindex of 11, co-authored 14 publications receiving 756 citations.

Papers
More filters
Journal ArticleDOI

Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa

TL;DR: Progress made with mapping schistosomiasis across Africa using available epidemiological data and, more recently, climate-based risk prediction is reviewed, and future directions for an integrated rapid mapping approach targeting multiple NTDs simultaneously are outlined, including potential challenges in developing an integrated survey tool.
Journal ArticleDOI

Partial DNA sequences from the mitochondrial cytochrome oxidase subunit I (COI) gene can differentiate the intermediate snail hosts Bulinus globosus and B. nasutus (Gastropoda: Planorbidae)

TL;DR: In order to test the current taxonomic status of two East African snail species within the Bulinus africanus group and develop molecular methods for subsequent identification, snails from Zanzibar were investigated and assayed for DNA sequence variation.
Journal ArticleDOI

A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia

TL;DR: The prevalences of infection with at least one soil-transmitted helminth and of anaemia were alarmingly high among the pre-school children, and the future integration of pre- school children within ongoing anthelmintic-control programmes in schools is strongly recommended.
Journal ArticleDOI

Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes.

TL;DR: The results serve to both illustrate the success of current control activities in reducing schistosome-induced morbidity, and to highlight key tools and techniques for continued application within ongoing and future mass drug administration programmes.